Elevance Health Inc (NYSE: ELV) has a higher price-to-earnings ratio of 19.14x compared to its average ratio, The 36-month beta value for ELV is at 0.84. Analysts have varying views on the stock, with 12 analysts rating it as a “buy,” 7 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ELV is 230.92M, and currently, shorts hold a 0.77% of that float. The average trading volume for ELV on September 13, 2024 was 973.72K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ELV) stock’s latest price update
Elevance Health Inc (NYSE: ELV)’s stock price has soared by 0.45 in relation to previous closing price of 543.39. Nevertheless, the company has seen a gain of 0.27% in its stock price over the last five trading days. seekingalpha.com reported 2024-09-06 that Elevance Health has shown consistent earnings growth, with a 16% CAGR since 2014, and recent quarterly results exceeded expectations despite a slight revenue decline. The company’s Carelon segment is a key growth driver, benefiting from cost savings and external revenue, with nearly 10% growth year-over-year. Elevance has a strong dividend growth history, with a 14.5% CAGR over the last decade, supported by robust earnings and a low payout ratio.
ELV’s Market Performance
Elevance Health Inc (ELV) has seen a 0.27% rise in stock performance for the week, with a 2.67% gain in the past month and a 2.87% surge in the past quarter. The volatility ratio for the week is 1.64%, and the volatility levels for the past 30 days are at 1.59% for ELV. The simple moving average for the past 20 days is -0.05% for ELV’s stock, with a 6.28% simple moving average for the past 200 days.
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with BofA Securities repeating the rating for ELV by listing it as a “Neutral.” The predicted price for ELV in the upcoming period, according to BofA Securities is $530 based on the research report published on July 18, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see ELV reach a price target of $643. The rating they have provided for ELV stocks is “Overweight” according to the report published on June 24th, 2024.
Robert W. Baird gave a rating of “Outperform” to ELV, setting the target price at $649 in the report published on May 30th of the current year.
ELV Trading at 2.22% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.77% of loss for the given period.
Volatility was left at 1.59%, however, over the last 30 days, the volatility rate increased by 1.64%, as shares surge +1.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.85% upper at present.
During the last 5 trading sessions, ELV rose by +0.27%, which changed the moving average for the period of 200-days by +14.02% in comparison to the 20-day moving average, which settled at $546.48. In addition, Elevance Health Inc saw 15.75% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from PERU RAMIRO G, who sale 753 shares at the price of $531.52 back on Aug 05 ’24. After this action, PERU RAMIRO G now owns 8,744 shares of Elevance Health Inc, valued at $400,235 using the latest closing price.
RAMIRO G PERU, the Director of Elevance Health Inc, proposed sale 753 shares at $531.52 during a trade that took place back on Aug 05 ’24, which means that RAMIRO G PERU is holding shares at $400,235 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.89 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.54. Equity return is now at value 16.65, with 6.02 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 0.66. The interest coverage ratio of the stock is 36.29.
Currently, EBITDA for the company is 1.74 billion with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of 0.86. The receivables turnover for the company is 8.94for trailing twelve months and the total asset turnover is 1.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.49.
Conclusion
In conclusion, Elevance Health Inc (ELV) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
